Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.083162563491086.7278
Domestic EquitiesLupin Limited7.99232883991663.8659
Domestic EquitiesDivi's Laboratories Limited6.5637850754545.2057
Domestic EquitiesDr. Reddy's Laboratories Limited5.80683749746482.3298
Domestic EquitiesCipla Limited5.67283495054471.2032
Domestic EquitiesApollo Hospitals Enterprise Limited5.1676548795429.2400
Domestic EquitiesMedPlus Health Services Limited3.70143627277307.4480
Domestic EquitiesMax Healthcare Institute Limited3.49432658082290.2493
Domestic EquitiesVijaya Diagnostic Centre Limited3.49092886684289.9674
Domestic EquitiesAjanta Pharma Limited3.4109946323283.3196
Domestic EquitiesSai Life Sciences Limited3.07152555745255.1272
Domestic EquitiesMankind Pharma Limited3.06091131195254.2474
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited2.8273913226234.8452
Domestic EquitiesIPCA Laboratories Limited2.51201364742208.6554
Domestic EquitiesAurobindo Pharma Limited2.50161702630207.7890
Domestic EquitiesAbbott India Limited2.369574187196.8181
Domestic EquitiesAlkem Laboratories Limited2.1976323678182.5382
Domestic EquitiesThyrocare Technologies Limited2.08154392120172.8958
Domestic EquitiesDr. Lal Path Labs Limited2.05311218224170.5392
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.9769799649164.2079
Domestic EquitiesPfizer Limited1.9395318249161.1040
Domestic EquitiesNarayana Hrudayalaya Limited1.8161823911150.8499
Domestic EquitiesGland Pharma Limited1.7562800549145.8760
Domestic EquitiesEmcure Pharmaceuticals Limited1.3078746337108.6294
Domestic EquitiesSuraksha Diagnostic Limited1.27333896349105.7664
Domestic EquitiesFortis Healthcare Limited1.25281103889104.0581
Domestic EquitiesSanofi Consumer Healthcare India Limited1.154821365995.9179
Domestic EquitiesSanofi India Limited1.099223027291.3052
Domestic EquitiesBiocon Limited1.0415221937486.5112
Domestic EquitiesSyngene International Limited0.9573188337279.5160
Domestic EquitiesAnthem Biosciences Limited0.8936105850374.2275
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8905151526473.9676
Domestic EquitiesAstraZeneca Pharma India Limited0.66666256855.3664
Domestic EquitiesIndoco Remedies Limited0.4468183492437.1168
Domestic EquitiesConcord Biotech Limited0.164211173813.6387
Total 99.6957 8281.0712
Cash & Cash Equivalents and Net AssetsTriparty Repo0.3371 27.9971
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0028 0.2292
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.0355 -2.9478
Total 0.3043 25.2785
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.